Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

Correction to: Clinical Pharmacokinetics 10.1007/s40262-018-0721-y

Introduction section, para 3, lines 2–4 which previously read:

In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT02418455),…

should read:

In an open-label, phase I/II, dose-finding trial (ClinicalTrials.gov identifier: NCT01856218),…

The original article was corrected.